Images List Premium Download Classic

Cancer

Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Methods for determining breast cancer risk
Silbiotech, Inc.
August 09, 2018 - N°20180224458

The present disclosure relates generally to determining the risk of developing breast cancer. In particular, the present disclosure provides materials and methods for determining whether a subject diagnosed with a non-cancerous breast tumor will develop cancer based on expression of multiple oncogenic biomarkers in the non-cancerous breast tumor.
Anti-pancreatic cancer monoclonal antibody and use thereof
Nanjing Markerline Biomedical Technology Co., Ltd.
August 09, 2018 - N°20180224457

A hybridoma cell line nm002-1 secreting an anti-human pancreatic cancer monoclonal antibody and deposited under cctcc accession no: c201173. Also, an anti-human pancreatic cancer monoclonal antibody nj002-1 secreted by the hybridoma cell line nm002-1 and use thereof..
Method for determining a subject's probability to suffer from pancreatic cancer
Reccan Diagnostics Ab
August 09, 2018 - N°20180224456

A method for determining a subject's probability to suffer from pancreatic cancer, wherein the level of platelet glycoprotein v (gp5), or a peptide fragment thereof is used as a biomarker. An increased level of gp5, or a peptide fragment thereof, is indicative for an increased probability to suffer from pancreatic cancer..
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Biomarker combinations for prostate disease
Minomic International Ltd.
August 09, 2018 - N°20180224454

The present invention relates to the diagnosis of prostate disease and the identification of biomarkers in biological samples which can be used in the detection of prostate disease. The invention further relates to the use of the biomarker glycipan-1 (gpc-1) in combination with other biomarkers in diagnostic methods which differentiate between prostate cancer and non-cancerous forms of prostate disease such ...
Immunologically active polypeptide
Institute Of Arthritis Research, Llc
August 09, 2018 - N°20180224447

Disclosed are immunomodulatory polypeptides that elicit an unusual induced cytokine profile, compositions comprising such polypeptides, compositions comprising antibodies that specifically bind to such polypeptides, and methods of using the same, including in cancer treatment, in the treatment of autoimmune diseases, in organ transplantation and for reducing graft rejection, for promoting fertility, and for identifying a neutrophil subset and/or other ...
Gdf-15 as a haematological toxicity biomarker
Novartis Ag
August 09, 2018 - N°20180224431

The present disclosure relates to use of gdf-15 as a safety biomarker for determining a toxicological effect of a mdm2 inhibitor; an ex vivo method for determining a toxicological effect of a mdm2 inhibitor in a subject, in particular for determining a likelihood of developing thrombocytopenia in a subject in response to administration of a dose of a mdm2 inhibitor; ...
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of purifying tumor cells using shear stress
University Of Iowa Research Foundation
August 09, 2018 - N°20180224359

Methods for isolating viable cancer cells from a sample that comprises a mixture of cancerous cells and normal (non-cancerous) cells are provided. In the methods, a fluid preparation comprising a mixture of cancerous and normal cells is repeatedly exposed to fluid shear stresses, whereby the repeated exposure to the fluid shear stresses preferentially imparts fluid shear stress-resistance to the cancerous ...
Probe combination for detection of cancer
Tcm Biotech Internationl Corp.
August 09, 2018 - N°20180223380

A probe combination for detecting cancer includes one or more sets of partial hepatitis b virus (hbv) targeting probes. When sequences of each of the sets of partial hbv targeting probes are aligned, an overall sequence of the aligned set of probes matches a reference sequence of a genome of a hbv genotype or a direct repeat (dr) region on ...
Oligonucleotides and methods for detecting kras and pik3ca mutations
Siemens Healthcare Diagnostics Inc.
August 09, 2018 - N°20180223377

Provided are oligonucleotides that are capable of detecting kras and pik3ca mutations in both cancer patients and healthy individuals with high specificity in kpcr assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of kras codon 12, 13, and 61 and pik3ca codon 542, 545, and 1047 single nucleotide ...
Compositions and methods for identifying anti-cancer, anti-metastatic and anti-stress agents
The Regents Of The University Of California
August 09, 2018 - N°20180223376

In alternative embodiments, provided are products of manufacture, such as assays, chimeric nucleic acids and nucleic acid constructs, recombinant cells, and methods, comprising use of beta3-integrin (itgb3) promoters operatively linked to a reporter, for drug screening, and in particular, screening for agents that inhibit cancer cell survival and metastasis. In alternative embodiments, compositions and methods as provided herein also ...
Prostate cancer prognostic compositions and kits
Stichting Katholieke Universiteit, The University Medical Centre Nijmegen
August 09, 2018 - N°20180223375

Described herein are method, compositions and kits for prognosis of prostate cancer. The methods include determining the ratio of pca3 and of a prostate-specific marker expression in a urine sample and correlating the value of the pca3/prostate-specific marker ratio with the aggressiveness and mortality risk of prostate cancer in the subject.
Identification of predictive biomarkers associated with wnt pathway inhibitors
Oncomed Pharmaceutical, Inc.
August 09, 2018 - N°20180223372

The present invention provides biomarkers for identifying tumors likely to respond to treatment with wnt pathway inhibitors. Also provided are methods for identifying tumors and/or patients that are likely to be responsive or non-responsive to treatment with a wnt pathway inhibitor.
Fgfr expression and susceptibility to an fgfr inhibitor
Debiopharm International Sa
August 09, 2018 - N°20180223371

A method of selecting a subject suffering from a cancer for a therapeutic regimen of administration of a pharmaceutical composition comprising an effective amount of an fgfr inhibitor is described, which method comprises (1) the taking of a tumor or liquid biopsy from the subject; (2) determination of the level of expression of any or all of fgfr1, fgfr2 and fgfr3, and (3) ...
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods for predicting the efficacy of treatment
Bioarray Genetics, Inc.
August 09, 2018 - N°20180223369

Clinical tests for testing therapeutic sensitivity of cancerous breast tissue and methods and kits for performing the same are described herein. Embodiments of the present invention are directed to methods for predicting the efficacy of treatment of breast cancer.
Assays, methods and compositions for diagnosing cancer
Gopath Global, Llc
August 09, 2018 - N°20180223367

The present invention provides a method and single-tube assay for identification and quantitative analysis of differentially methylated mlh1 promoter sequences that are associated with certain types of cancer in an individual by obtaining a biological sample comprising dna from the individual, detecting the presence of and measuring the level of methylated mlh1 promoter sequences, and comparing the presence of and ...
Diagnostic, predictive and prognostic testing for cancer
Cambridge Cancer Diagnostics Limited
August 09, 2018 - N°20180223366

The present invention relates generally to the field of cancer. In particular, the present invention relates to cancer prognostic and treatment protocols..
Microbiome identification and use in diagnosis of head and neck squamous cell cancer
The Johns Hopkins University
August 09, 2018 - N°20180223338

Methods for analyzing the bacterial microbiome of a subject and triaging the subject into treatment for head and neck squamous cell cancer from a saliva or tissue sample are provided. The methods also provide means for differentiation of different cancer patient cohorts from the bacterial microbiome of a subject..
Capsid-modified, raav3 vector compositions and uses in gene therapy of human liver cancer
University Of Florida Research Foundation, Incorporated
August 09, 2018 - N°20180223312

Disclosed are next-generation multi-mutated capsid protein-modified raav expression vectors, as well as infectious virions, compositions, and pharmaceutical formulations that include them. Also disclosed are methods of preparing and using these high transduction efficiency vector constructs in a variety of therapeutic applications including, inter alia, as delivery agents for the treatment or amelioration of one or more diseases or abnormal conditions ...
Compositions and methods for the modulation of dna damage responses using bal1 and bbap
Dana-farber Cancer Institute, Inc.
August 09, 2018 - N°20180223288

The invention provides methods and compositions for enhancing the efficacy of cancer therapies through modulation of bal1 and/or bbap. Also provided are methods for predicting the efficacy of cancer therapies or treating cancer in a subject through modulation of bal1 and/or bbap.
Therapeutic oligonucleotides
Ifom- Fondazione Istituto Firc Di Oncologia Molecolare
August 09, 2018 - N°20180223279

The present invention relates to an oligonucleotide comprising one of the following sequence: (ttaggg) seq id no. 1, (tagggt) seq id no.
Method for the induction and expansion of natural killer cells derived from peripheral blood mononuclear ...
Nkmax Co., Ltd.
August 09, 2018 - N°20180223257

The present invention relates to a method for inducing and expanding natural killer cells derived from peripheral blood mononuclear cells, which comprises co-culturing, as feeder cells, irradiated jurkat cells and irradiated epstein-barr virus transformed lymphocyte continuous line (ebv-lcl) cells in the presence of cytokines, along with peripheral blood mononuclear cells. According to the present invention, a large quantity of natural ...
Loading